Qiagen Historical Financial Ratios

QGEN Stock

USD 43.43 0.32 0.73%

Qiagen NV is promptly reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 18.07, Free Cash Flow Yield of 0.0158, Invested Capital of 0.0 or Operating Cash Flow Per Share of 2.18 will help investors to properly organize and evaluate Qiagen NV financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

About Qiagen Financial Ratios Analysis

Qiagen NVFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Qiagen NV investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Qiagen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Qiagen NV history.

Qiagen NV Financial Ratios Chart

At this time, Qiagen NV's ROIC is very stable compared to the past year. As of the 29th of November 2024, Inventory Turnover is likely to grow to 1.94, while PTB Ratio is likely to drop 2.47.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share Pb Ratio Cash Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Qiagen NV stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Qiagen NV sales, a figure that is much harder to manipulate than other Qiagen NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most ratios from Qiagen NV's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Qiagen NV current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.At this time, Qiagen NV's ROIC is very stable compared to the past year. As of the 29th of November 2024, Inventory Turnover is likely to grow to 1.94, while PTB Ratio is likely to drop 2.47.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	76.13	56.84	95.77	58.16
PTB Ratio	3.97	3.18	2.6	2.47

Days Sales Outstanding Ptb Ratio

Qiagen NV fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.04	0.04	0.42	-0.28	0.6	0.62	0.04	0.99	0.46	0.25	-0.39	0.41	0.22	-0.25	0.33	0.6	0.47	0.25	0.18	0.07	0.1	0.08	0.13	0.51	0.12
Ptb Ratio	0.04		-0.49	-0.77	-0.36	-0.35	0.28	1.0	-0.04	-0.26	0.74	-0.67	-0.17	0.83	-0.72	-0.29	-0.32	0.62	0.02	-0.01	0.31	0.89	-0.01	0.66	0.58	0.11
Days Sales Outstanding	0.04	-0.49		0.3	-0.22	0.11	0.02	-0.49	0.15	-0.18	-0.56	0.37	-0.21	-0.5	0.34	0.6	0.21	-0.42	0.04	0.31	0.38	-0.53	-0.24	-0.66	-0.35	-0.25
Book Value Per Share	0.42	-0.77	0.3		0.33	0.75	0.11	-0.77	0.45	0.68	-0.24	0.1	0.65	-0.35	0.44	0.25	0.68	-0.29	0.38	-0.03	-0.35	-0.64	-0.05	-0.21	-0.26	-0.14
Free Cash Flow Yield	-0.28	-0.36	-0.22	0.33		0.42	-0.62	-0.36	-0.27	0.66	-0.04	0.22	0.5	-0.27	0.58	-0.56	0.22	-0.68	0.3	-0.83	-0.78	-0.53	0.28	0.17	-0.72	0.17
Operating Cash Flow Per Share	0.6	-0.35	0.11	0.75	0.42		0.29	-0.35	0.62	0.91	0.2	-0.22	0.8	-0.05	0.16	0.2	0.79	-0.27	0.72	-0.21	-0.27	-0.38	-0.03	0.16	-0.26	-0.08
Capex To Depreciation	0.62	0.28	0.02	0.11	-0.62	0.29		0.28	0.58	0.02	0.42	-0.62	0.15	0.48	-0.74	0.67	0.2	0.55	0.3	0.7	0.49	0.52	-0.26	0.16	0.56	-0.21
Pb Ratio	0.04	1.0	-0.49	-0.77	-0.36	-0.35	0.28		-0.04	-0.26	0.74	-0.67	-0.17	0.83	-0.72	-0.29	-0.32	0.62	0.02	-0.01	0.31	0.89	-0.01	0.66	0.58	0.11
Ev To Sales	0.99	-0.04	0.15	0.45	-0.27	0.62	0.58	-0.04		0.45	0.14	-0.3	0.36	0.12	-0.17	0.39	0.64	0.38	0.24	0.19	0.1	0.0	0.08	0.02	0.43	0.12
Free Cash Flow Per Share	0.46	-0.26	-0.18	0.68	0.66	0.91	0.02	-0.26	0.45		0.3	-0.24	0.89	0.03	0.25	-0.2	0.73	-0.25	0.64	-0.53	-0.55	-0.34	0.11	0.37	-0.26	0.05
Roic	0.25	0.74	-0.56	-0.24	-0.04	0.2	0.42	0.74	0.14	0.3		-0.83	0.47	0.85	-0.6	-0.28	0.05	0.47	0.52	-0.16	0.03	0.68	-0.18	0.92	0.41	-0.12
Inventory Turnover	-0.39	-0.67	0.37	0.1	0.22	-0.22	-0.62	-0.67	-0.3	-0.24	-0.83		-0.4	-0.95	0.75	0.07	-0.21	-0.59	-0.48	-0.07	-0.12	-0.72	0.09	-0.74	-0.54	0.01
Net Income Per Share	0.41	-0.17	-0.21	0.65	0.5	0.8	0.15	-0.17	0.36	0.89	0.47	-0.4		0.2	0.1	-0.22	0.67	-0.08	0.74	-0.41	-0.54	-0.19	0.01	0.58	-0.11	-0.04
Days Of Inventory On Hand	0.22	0.83	-0.5	-0.35	-0.27	-0.05	0.48	0.83	0.12	0.03	0.85	-0.95	0.2		-0.77	-0.24	-0.04	0.68	0.27	0.02	0.15	0.85	-0.06	0.77	0.63	0.03
Payables Turnover	-0.25	-0.72	0.34	0.44	0.58	0.16	-0.74	-0.72	-0.17	0.25	-0.6	0.75	0.1	-0.77		-0.24	0.1	-0.7	-0.05	-0.5	-0.48	-0.92	0.21	-0.44	-0.67	0.12
Capex To Revenue	0.33	-0.29	0.6	0.25	-0.56	0.2	0.67	-0.29	0.39	-0.2	-0.28	0.07	-0.22	-0.24	-0.24		0.15	-0.01	0.08	0.84	0.64	-0.07	-0.38	-0.55	0.04	-0.38
Cash Per Share	0.6	-0.32	0.21	0.68	0.22	0.79	0.2	-0.32	0.64	0.73	0.05	-0.21	0.67	-0.04	0.1	0.15		-0.08	0.46	-0.13	-0.17	-0.31	-0.07	0.11	-0.04	-0.08
Pocfratio	0.47	0.62	-0.42	-0.29	-0.68	-0.27	0.55	0.62	0.38	-0.25	0.47	-0.59	-0.08	0.68	-0.7	-0.01	-0.08		-0.24	0.38	0.29	0.79	-0.02	0.4	0.99	0.08
Interest Coverage	0.25	0.02	0.04	0.38	0.3	0.72	0.3	0.02	0.24	0.64	0.52	-0.48	0.74	0.27	-0.05	0.08	0.46	-0.24		-0.21	-0.16	-0.09	-0.11	0.47	-0.27	-0.12
Capex To Operating Cash Flow	0.18	-0.01	0.31	-0.03	-0.83	-0.21	0.7	-0.01	0.19	-0.53	-0.16	-0.07	-0.41	0.02	-0.5	0.84	-0.13	0.38	-0.21		0.75	0.3	-0.45	-0.4	0.42	-0.41
Pfcf Ratio	0.07	0.31	0.38	-0.35	-0.78	-0.27	0.49	0.31	0.1	-0.55	0.03	-0.12	-0.54	0.15	-0.48	0.64	-0.17	0.29	-0.16	0.75		0.39	-0.64	-0.27	0.33	-0.55
Days Payables Outstanding	0.1	0.89	-0.53	-0.64	-0.53	-0.38	0.52	0.89	0.0	-0.34	0.68	-0.72	-0.19	0.85	-0.92	-0.07	-0.31	0.79	-0.09	0.3	0.39		-0.13	0.57	0.74	-0.02
Income Quality	0.08	-0.01	-0.24	-0.05	0.28	-0.03	-0.26	-0.01	0.08	0.11	-0.18	0.09	0.01	-0.06	0.21	-0.38	-0.07	-0.02	-0.11	-0.45	-0.64	-0.13		0.01	-0.02	0.99
Roe	0.13	0.66	-0.66	-0.21	0.17	0.16	0.16	0.66	0.02	0.37	0.92	-0.74	0.58	0.77	-0.44	-0.55	0.11	0.4	0.47	-0.4	-0.27	0.57	0.01		0.32	0.06
Ev To Operating Cash Flow	0.51	0.58	-0.35	-0.26	-0.72	-0.26	0.56	0.58	0.43	-0.26	0.41	-0.54	-0.11	0.63	-0.67	0.04	-0.04	0.99	-0.27	0.42	0.33	0.74	-0.02	0.32		0.09
Pe Ratio	0.12	0.11	-0.25	-0.14	0.17	-0.08	-0.21	0.11	0.12	0.05	-0.12	0.01	-0.04	0.03	0.12	-0.38	-0.08	0.08	-0.12	-0.41	-0.55	-0.02	0.99	0.06	0.09

Click cells to compare fundamentals

Qiagen NV Account Relationship Matchups

Qiagen NV fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	4.87	6.26	5.46	5.14	5.04	6.94
Ptb Ratio	2.93	4.72	3.97	3.18	2.6	2.47
Days Sales Outstanding	102.16	85.84	76.13	56.84	95.77	58.16
Book Value Per Share	11.53	11.21	14.0	15.7	17.21	18.07
Free Cash Flow Yield	0.007526	0.0161	0.0352	0.0514	0.0299	0.0158
Operating Cash Flow Per Share	1.5	2.22	2.89	3.24	2.08	2.18
Stock Based Compensation To Revenue	0.0432	0.0219	0.0171	0.0231	0.024	0.0228
Pb Ratio	2.93	4.72	3.97	3.18	2.6	2.47
Ev To Sales	5.58	7.03	5.93	5.67	5.52	7.33
Roic	0.0422	0.0599	0.1	0.0824	0.0665	0.0739
Inventory Turnover	3.05	2.21	2.45	2.11	1.86	1.94
Net Income Per Share	(0.19)	0.33	2.32	1.92	1.54	1.62
Days Of Inventory On Hand	119.55	165.41	149.28	172.61	195.87	187.92
Payables Turnover	6.15	5.44	7.91	7.67	8.82	5.02
Sales General And Administrative To Revenue	0.0735	0.0589	0.0569	0.0606	0.0607	0.0576
Cash Per Share	3.42	3.22	4.82	6.42	4.78	5.02
Pocfratio	22.47	23.79	19.23	15.39	21.56	39.99
Interest Coverage	4.53	7.6	11.57	9.11	8.34	4.47
Capex To Operating Cash Flow	0.83	0.62	0.32	0.21	0.35	0.68
Pfcf Ratio	132.87	62.28	28.42	19.45	33.4	35.07
Days Payables Outstanding	59.37	67.12	46.14	47.61	41.38	79.42
Income Quality	(7.98)	6.68	1.25	1.69	1.35	1.47
Roe	(0.0163)	0.0297	0.17	0.12	0.0896	0.0983
Ev To Operating Cash Flow	25.75	26.69	20.9	16.97	23.62	41.92
Pe Ratio	(179.35)	159.02	23.98	26.01	29.03	27.58
Return On Tangible Assets	0.0602	(0.0168)	0.0273	0.16	0.12	0.11
Ev To Free Cash Flow	152.22	69.88	30.87	21.45	36.58	38.41
Earnings Yield	(0.005576)	0.006289	0.0417	0.0384	0.0344	0.0362
Intangibles To Total Assets	0.53	0.55	0.48	0.46	0.49	0.3
Net Debt To E B I T D A	4.75	2.0	1.19	1.45	1.37	1.06
Current Ratio	1.65	2.67	1.39	2.46	1.99	3.34
Tangible Book Value Per Share	(1.07)	(3.56)	0.54	2.58	3.64	3.82
Receivables Turnover	3.57	4.25	4.79	6.42	3.81	5.73
Graham Number	6.99	9.15	27.02	26.03	24.43	25.66
Shareholders Equity Per Share	11.53	11.21	14.0	15.7	17.21	18.07
Debt To Equity	0.83	0.67	0.77	0.54	0.4	0.37

Pair Trading with Qiagen NV

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.

Moving together with Qiagen Stock

0.67	A	Agilent Technologies Sell-off Trend	Pair Corr
0.73	ME	23Andme Holding Upward Rally	Pair Corr
0.62	VALN	Valneva SE ADR	Pair Corr

Moving against Qiagen Stock

0.73	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.43	VCYT	Veracyte	Pair Corr
0.42	VERA	Vera Therapeutics	Pair Corr
0.31	VANI	Vivani Medical	Pair Corr

The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.

The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Qiagen NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qiagen NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:

How To Invest In Qiagen

Details

Is Qiagen Stock a good investment?

Details

What is Qiagen NV's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.255

Earnings Share

0.45

Revenue Per Share

8.841

Quarterly Revenue Growth

0.055

Return On Assets

0.0484

The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Qiagen Historical Financial Ratios

About Qiagen Financial Ratios Analysis

Qiagen NV Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Qiagen NV fundamentals Correlations

Qiagen NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Qiagen NV fundamentals Accounts

Pair Trading with Qiagen NV

Moving together with Qiagen Stock

Moving against Qiagen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Ev To Operating Cash Flow	+ 0.99	Pocfratio
Pe Ratio	+ 0.99	Income Quality
Roe	+ 0.92	Roic
Free Cash Flow Per Share	+ 0.91	Operating Cash Flow Per Share

Days Of Inventory On Hand	- 0.95	Inventory Turnover
Days Payables Outstanding	- 0.92	Payables Turnover
Inventory Turnover	- 0.83	Roic
Capex To Operating Cash Flow	- 0.83	Free Cash Flow Yield
Pfcf Ratio	- 0.78	Free Cash Flow Yield
Payables Turnover	- 0.77	Days Of Inventory On Hand